Haverford Financial Services’s GSK GSK Stock Holding History

Haverford Financial Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,101	Closed	-$307K	–	79
2018 Q2	$307K	Sell	6,101 -1,765	-22%	-$88.9K	0.12%	64
2018 Q1	$384K	Sell	7,866 -712	-8%	-$33.2K	0.15%	56
2017 Q4	$380K	Buy	8,578 +4,103	+92%	+$190K	0.14%	57
2017 Q3	$227K	Hold	4,475	–	–	0.09%	73
2017 Q2	$241K	Buy	4,475 +12	+0.3%	+$640	0.1%	52
2017 Q1	$235K	Buy	+4,463	New	+$226K	0.1%	54
2016 Q4	–	Sell	-4,474	Closed	-$241K	–	61
2016 Q3	$241K	Sell	4,474 -40	-0.9%	-$2.19K	0.1%	54
2016 Q2	$245K	Sell	4,514 -35	-0.8%	-$1.84K	0.1%	57
2016 Q1	$231K	Buy	+4,549	New	+$227K	0.1%	57
2014 Q4	–	Sell	-4,418	Closed	-$254K	–	46
2014 Q3	$254K	Buy	4,418 +271	+7%	+$16.6K	0.11%	45
2014 Q2	$277K	Sell	4,147 -643	-13%	-$43.5K	0.12%	41
2014 Q1	$320K	Sell	4,790 -292	-6%	-$19.7K	0.15%	34
2013 Q4	$339K	Buy	5,082 +24	+0.5%	+$1.56K	0.16%	38
2013 Q3	$317K	Buy	+5,058	New	+$326K	0.17%	34

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Haverford Financial Services's GSK Position: Q3 2018 in Review

Haverford Financial Services sold out of GSK (GSK) in Q3 2018, closing a stake of 6,101 shares — an estimated $307K sold.

Haverford Financial Services first reported a position in GSK in Q3 2013 and held it in 14 quarters. The position peaked at $384K in Q1 2018. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

Haverford Financial Services reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
Haverford Financial Services sold 6,101 GSK shares in Q3 2018, an estimated $307K.
Haverford Financial Services first reported a position in GSK in Q3 2013 and held it in 14 quarters.
Haverford Financial Services's GSK position peaked at $384K in Q1 2018.
787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on Haverford Financial Services's 13F filing for Q3 2018, filed 8 Nov 2018.